Boutry, Maxime
Morais, Sara
Stevanin, Giovanni
Article History
First Online: 28 February 2019
Compliance with Ethical Standards
:
: Giovanni Stevanin reports grants from the European Union H2020 programme, grants from Spastic Paraplegia Foundation, grants from Association Strumpell Lorrain, grants from Agence Nationale de la Recherche, and grants from Erare Program, during the conduct of the study. In addition, Dr. Stevanin has been issued a patent on Inhibitors of glucosylceramide synthase for the treatment of motor neuron diseases. Maxime Boutry reports personal fees from French Ministry of Research (Doctoral School ED3C), during the conduct of the study. In addition, Dr. Boutry has been issued a patent on Inhibitors of glucosylceramide synthase for the treatment of motor neuron diseases. Sara Morais reports personal fees from FCT (Fundação para a Ciência e Tecnologia), Portugal, during the conduct of the study.
: This article is a review and reports only studies approved by editorial boards based on peer reviews. When we cited our own work, all the procedures performed in the studies involving human materials or animals were conducted in accordance with the ethical standards of our institution, with informed consent obtained from patients and approval from ethics committees.